$0
No Cell Therapy-Related Updates in May’s CHMP Agenda; Abecma Likely to Be Included in June’s Agenda
On Monday, May 22, the CHMP Agenda for May was released. Of note, Abecma’s (BMS’s BCMA CAR-T) Type II Variation (T2V) for ≥3L MM was absent from the agenda, and no other cell therapy-related updates were observed. Therefore, based on the agenda, no updates are expected on the CHMP highlights to be published on Friday, May 26.